Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 2/2022

14.07.2020 | Original Article

Study of Efficacy of Intraoral Submucosal Injections of Corticosteroids and Placentrex in the Management of Oral Submucous Fibrosis

verfasst von: C. Niranjan Reddy, B. P. Belaldavar, Rajesh Radhakrishna Havaldar

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Sonderheft 2/2022

Einloggen, um Zugang zu erhalten

Abstract

In a country such as India, popularly known for its rich diversity and traditions, chewing tobacco and its many other forms is a commonly practised entity. The resultant of this leads to oral submucous fibrosis (OSMF) which causes permanent morbidity in the form of trismus and also can lead to potential possibility of oral cancer. Intra oral injections of steroids such as hyaluronidase and placentrex have been postulated by many studies. But this study was done to evaluate the efficacy of both these commonly used treatment modalities. A 1 year hospital based study was performed over 30 patients diagnosed to be having oral submucosal fibrosis. They were randomly given injection hyaluronidase and injection placentrex. In addition to this, routine haemogram was done and the inter incisor distance was measured before and after the treatment along with histopathological study of the oral lesions. With a prevalence of 0.31%, the males out numbered females. Majority of the patients were in their third decade. All patients chewed tobacco in one or the other form and 90% of them presented with burning sensation in the mouth. The mean inter incisor distance in our patients was 3.1%. A third of the cases were anaemic and two thirds had an elevated erythrocyte sedimentation rate and serum globulin level. More than half the cases had an elevated absolute eosinophil count. All 30 biopsy specimens showed atrophic oral mucosa with subepithelial dense collagenised fibrous tissue. The group of patients who were treated with injection placentrex showed slightly better results than corticosteroids. The results were not statistically significant although clinically they were noteworthy. Being a silent, chronic disease, oral submucosal fibrosis affects the most productive population fraction of our country causing morbidity and also acts as precursor for oral cancer. Since the etiological agent is chewing areacnut in one form or the other, considerable efforts have to be made in sensitizing the workforce of the nation at the community level in understanding the ill effects of chewing tobacco. Understanding the associated conditions such as anaemia, elevated erythrocyte sedimentation rate, serum globulins and absolute eosinophil count should prompt the otolaryngologist in treating these patients holistically. Though injection placentrex yielded better improvement in the inter incisor distance, the results with steroid injection was also comparable with no statistical significance. Hence, keeping the premalignant nature of the disease, screening the patients promptly and treating them on time would lead to considerable reduction in the morbidity caused by the disease. Coupled with health education, the results could be even more encouraging.
Literatur
1.
Zurück zum Zitat Schwartz J (1962) Atrophia idiopathica (tropical) mucosa oris. Indian J Otolaryngol 30:5 Schwartz J (1962) Atrophia idiopathica (tropical) mucosa oris. Indian J Otolaryngol 30:5
2.
Zurück zum Zitat Joshi SC (1953) Submucous fibrosis of palate and pillars. Indian J Otolaryngol 4:1 Joshi SC (1953) Submucous fibrosis of palate and pillars. Indian J Otolaryngol 4:1
3.
Zurück zum Zitat Pindborg JJ, Sirsat SM (1966) Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 22:764–779CrossRefPubMed Pindborg JJ, Sirsat SM (1966) Oral submucous fibrosis. Oral Surg Oral Med Oral Pathol 22:764–779CrossRefPubMed
4.
Zurück zum Zitat Gupta D, Sharma SC (1988) Oral submucous fibrosis: a new treatment regimen. J Oral Maxillofac Surg 46:830–833CrossRefPubMed Gupta D, Sharma SC (1988) Oral submucous fibrosis: a new treatment regimen. J Oral Maxillofac Surg 46:830–833CrossRefPubMed
5.
Zurück zum Zitat Axell T (1993) The professional role of the dentist under the aspects of precancer and cancer diagnosis and management. Int Dent J 43:609–611PubMed Axell T (1993) The professional role of the dentist under the aspects of precancer and cancer diagnosis and management. Int Dent J 43:609–611PubMed
6.
Zurück zum Zitat Van SHA, Wyk CW (1988) Betel chewing and dietary habits of chewers without and with submucous fibrosis and with concomitant oral cancer. S Afr Med J 74(3):572–575 Van SHA, Wyk CW (1988) Betel chewing and dietary habits of chewers without and with submucous fibrosis and with concomitant oral cancer. S Afr Med J 74(3):572–575
7.
Zurück zum Zitat Lai DR, Chen HR, Lin LM et al (1995) Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10 year experience with 150 cases. J Oral Pathol Med 24:402–406CrossRefPubMed Lai DR, Chen HR, Lin LM et al (1995) Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10 year experience with 150 cases. J Oral Pathol Med 24:402–406CrossRefPubMed
8.
9.
Zurück zum Zitat Pandya S, Chaudhary A, Singh M, Singh M, Mehrotra R (2009) Correlation of histopathological diagnosis with habits and clinical findings in oral submucous fibrosis. Head Neck Oncol 1:10CrossRefPubMedPubMedCentral Pandya S, Chaudhary A, Singh M, Singh M, Mehrotra R (2009) Correlation of histopathological diagnosis with habits and clinical findings in oral submucous fibrosis. Head Neck Oncol 1:10CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Borle RM, Borle SR (1991) Management of Oral Submucous fibrosis. A conservative approach. Int J Oral Maxillofac Surg 49:788–791CrossRef Borle RM, Borle SR (1991) Management of Oral Submucous fibrosis. A conservative approach. Int J Oral Maxillofac Surg 49:788–791CrossRef
11.
Zurück zum Zitat Khanna JN, Andrade NN (1995) Oral Submucous fibrosis: a new concept in surgical management. Int J Maxillofac Surg 24:433–439CrossRef Khanna JN, Andrade NN (1995) Oral Submucous fibrosis: a new concept in surgical management. Int J Maxillofac Surg 24:433–439CrossRef
12.
Zurück zum Zitat Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Pindborg JJ, Mehta FS (1995) Etiology of oral submucous fibrosis with special reference to the role of areca nut chewing. J Oral Pathol Med 24:145–152CrossRefPubMed Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Pindborg JJ, Mehta FS (1995) Etiology of oral submucous fibrosis with special reference to the role of areca nut chewing. J Oral Pathol Med 24:145–152CrossRefPubMed
13.
Zurück zum Zitat Caniff JP, Harvey W, Harris M (1986) OSMF: its pathogenesis and management. Br Dent J 160:429–434CrossRef Caniff JP, Harvey W, Harris M (1986) OSMF: its pathogenesis and management. Br Dent J 160:429–434CrossRef
14.
Zurück zum Zitat Kiran Kumar K, Saraswathi TR, Ranganathan K, Uma Devi M, Elizabeth J (2007) Oral submucous fibrosis: a clinico-histopathological study in Chennai. Indian J Dent Res 18:106–111CrossRefPubMed Kiran Kumar K, Saraswathi TR, Ranganathan K, Uma Devi M, Elizabeth J (2007) Oral submucous fibrosis: a clinico-histopathological study in Chennai. Indian J Dent Res 18:106–111CrossRefPubMed
15.
Zurück zum Zitat Bailoor DN (1993) Oral submucous fibrosis: the Mangalore Study. J Indian Acad Oral Med Radiol IV 3,4:12–15 Bailoor DN (1993) Oral submucous fibrosis: the Mangalore Study. J Indian Acad Oral Med Radiol IV 3,4:12–15
16.
Zurück zum Zitat Phatak AG (1978) Serum proteins and immunoglobulins in oral submucous fibrosis. Indian J Otolaryngol 30:1–4CrossRef Phatak AG (1978) Serum proteins and immunoglobulins in oral submucous fibrosis. Indian J Otolaryngol 30:1–4CrossRef
17.
Zurück zum Zitat Sinha SN, Jain PK (1978) Intraoral injection of hydrocortisone and placental extract in oral submucous fibrosis. Indian J Otolaryngol 30(2):103–104CrossRef Sinha SN, Jain PK (1978) Intraoral injection of hydrocortisone and placental extract in oral submucous fibrosis. Indian J Otolaryngol 30(2):103–104CrossRef
18.
Zurück zum Zitat Ramanjaneyulu P, Prabhakara Rao BSRC (1980) Submucous fibrosis: new treatment. J Indian Dent Assoc 52:379–380 Ramanjaneyulu P, Prabhakara Rao BSRC (1980) Submucous fibrosis: new treatment. J Indian Dent Assoc 52:379–380
19.
Zurück zum Zitat Kakar PK, Puri RK, Venkatachalam VP (1985) Oral submucous fibrosis: treatment with hyalase. J Laryngol Otol 99:57–59CrossRefPubMed Kakar PK, Puri RK, Venkatachalam VP (1985) Oral submucous fibrosis: treatment with hyalase. J Laryngol Otol 99:57–59CrossRefPubMed
Metadaten
Titel
Study of Efficacy of Intraoral Submucosal Injections of Corticosteroids and Placentrex in the Management of Oral Submucous Fibrosis
verfasst von
C. Niranjan Reddy
B. P. Belaldavar
Rajesh Radhakrishna Havaldar
Publikationsdatum
14.07.2020
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe Sonderheft 2/2022
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-020-01965-z

Weitere Artikel der Sonderheft 2/2022

Indian Journal of Otolaryngology and Head & Neck Surgery 2/2022 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.